Hunter Perkins Capital Management, LLC Catalent, Inc. Transaction History

Hunter Perkins Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$53.58 - $57.02 $46,882 - $49,892	-875 Reduced 2.86%	29,690 $1.67 Million
Q1 2024 Apr 23, 2024	SELL	$42.56 - $59.82 $96,824 - $136,090	-2,275 Reduced 6.93%	30,565 $1.73 Million
Q4 2023 Jan 18, 2024	SELL	$32.18 - $46.57 $15,285 - $22,120	-475 Reduced 1.43%	32,840 $1.48 Million
Q3 2023 Oct 19, 2023	SELL	$44.2 - $50.2 $4.47 Million - $5.07 Million	-101,075 Reduced 75.21%	33,315 $1.52 Million
Q2 2023 Jul 18, 2023	BUY	$31.86 - $67.26 $2.01 Million - $4.25 Million	63,215 Added 88.82%	134,390 $2.75 Million
Q1 2023 Apr 14, 2023	BUY	$45.44 - $74.26 $61,344 - $100,251	1,350 Added 1.93%	71,175 $4.68 Million
Q4 2022 Jan 17, 2023	BUY	$41.39 - $81.0 $2.89 Million - $5.66 Million	69,825 New	69,825 $3.14 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.